https://www.selleckchem.com/products/skl2001.html
Drug-induced liver injury (DILI) is a major adverse event caused by drug treatment, which can be categorized into three types hepatocellular, mixed, and cholestatic. Although nearly every class of drugs can cause DILI, an overall understanding of lipid profiles in DILI patients is lacking. We used lipidomics to analyze the plasma lipid profiles of patients to understand their hepatic pathophysiology and identify DILI biomarkers. We identified 463 lipids and compared their levels between the acute and recovery phases of the three types o